Mitsubishi Tanabe Pharma Corporation
Customers
0
None disclosed
Suppliers
1
0 disclosed
Latest period
Dec 31, 2021
10-K/A filed 2023-08-28
Suppliers 1
Companies that disclose Mitsubishi Tanabe Pharma Corporation as a major customer, as a share of their own revenue. 0 active, 1 lapsed.
| Company | % of their revenue | Est. $ from Mitsubishi Tanabe Pharma Corporation | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| AKBA Akebia Therapeutics, Inc. |
Named | — | FY 2021-12-31 | — | Lapsed Last seen 2021-12-31 |
10-K/A 2023-08-28 |
On February 25, 2021, we entered into a royalty interest acquisition agreement, or the Royalty Agreement, with HealthCare Royalty Partners IV, L.P., or HCR, pursuant to which we sold to HCR our right to the to receive royalties and sales milestones for vadadustat, collectively the Royalty Interest Payments, in each case, payable to us under our Collaboration Agreement dated December 11, 2015, or the MTPC Agreement, with Mitsubishi Tanabe Pharma Corporation, or MTPC, subject to an annual maximum “cap” of $13.0 million, or the Annual Cap, and an aggregate maximum “cap” of $150.0 million, or the Aggregate Cap. | ||||||
Alerts are coming
Get an email when Mitsubishi Tanabe Pharma Corporation's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.